|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Interest earned on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Income tax payable | ||
| Due to related party | ||
| Accrued offering costs and expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Cash withdrawn from Trust Account to pay for Franchise and Income Taxes | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of Class B common stock to Independent Directors | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from private placement | ||
| Proceeds from issuance of promissory note to related party | ||
| Repayment of promissory note – related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Cash – end of the period | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Non-Cash investing and financing activities: | ||
| Remeasurement of Class A common stock subject to redemption | ||
| Accretion of class a common stock subject to redemption | ||
| Deferred underwriting fee payable | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock | ||
| Forfeiture of Founder Shares at no consideration | ||
| Stock subscription receivable for purchase of 90,000 Founder Shares by Independent Directors | ||
| Federal income taxes paid |
Loading...
